Skip to main content

Table 1 Availability of subsidized ACT (AL), other forms of ACT and quinine in the three outlet types

From: Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya

 

Outlet type

Public n = 126 (%)

Private n = 96 (%)

Not-for-profit n = 66 (%)

Availability of anti-malarial drugs

   

Subsidized ACT (AL)

111 (88.1)

27 (28.1)

27 (40.9)

Other ACT

0 (0)

87 (90.6)

8 (12.0)

Quinine

59 (46.8)

68 (70.8)

36 (54.5)

  1. ACT, artemisinin-based combination therapy, AL, artemether-lumefantrine.